Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Hemorrhage | 68 | 2023 | 2647 | 6.210 |
Why?
|
Stroke | 47 | 2023 | 9975 | 3.270 |
Why?
|
Liver Transplantation | 18 | 2016 | 2119 | 1.940 |
Why?
|
Brain Ischemia | 13 | 2022 | 3264 | 1.720 |
Why?
|
Genome-Wide Association Study | 43 | 2024 | 12259 | 1.500 |
Why?
|
Fatty Liver | 10 | 2019 | 728 | 1.500 |
Why?
|
Atrial Fibrillation | 22 | 2023 | 5033 | 1.410 |
Why?
|
Reperfusion Injury | 7 | 2014 | 1027 | 1.250 |
Why?
|
Genetic Predisposition to Disease | 29 | 2023 | 17439 | 1.160 |
Why?
|
Microdialysis | 3 | 2017 | 158 | 1.120 |
Why?
|
Cerebrovascular Disorders | 3 | 2023 | 1504 | 1.110 |
Why?
|
Polymorphism, Single Nucleotide | 24 | 2023 | 15518 | 1.000 |
Why?
|
Hematoma | 11 | 2021 | 758 | 1.000 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 2 | 2015 | 92 | 0.990 |
Why?
|
Semaphorins | 1 | 2023 | 101 | 0.890 |
Why?
|
Brain Diseases | 2 | 2020 | 1558 | 0.740 |
Why?
|
Cerebral Amyloid Angiopathy | 6 | 2023 | 859 | 0.730 |
Why?
|
Subarachnoid Space | 2 | 2021 | 79 | 0.730 |
Why?
|
Mendelian Randomization Analysis | 9 | 2024 | 967 | 0.730 |
Why?
|
Boxing | 1 | 2019 | 15 | 0.720 |
Why?
|
Liver | 13 | 2022 | 7479 | 0.710 |
Why?
|
Hepatocytes | 3 | 2019 | 1211 | 0.690 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2015 | 1157 | 0.680 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2018 | 24 | 0.660 |
Why?
|
Prazosin | 1 | 2018 | 96 | 0.660 |
Why?
|
Risk Factors | 54 | 2023 | 72252 | 0.640 |
Why?
|
Early Ambulation | 1 | 2018 | 44 | 0.630 |
Why?
|
Genetic Variation | 14 | 2023 | 6535 | 0.630 |
Why?
|
Apolipoprotein E4 | 4 | 2020 | 668 | 0.620 |
Why?
|
Skin Temperature | 1 | 2018 | 93 | 0.620 |
Why?
|
Humans | 196 | 2024 | 743811 | 0.620 |
Why?
|
Capillaries | 2 | 2018 | 773 | 0.620 |
Why?
|
Transcription Factor CHOP | 2 | 2015 | 73 | 0.600 |
Why?
|
Skin | 8 | 2020 | 4372 | 0.590 |
Why?
|
Oxidative Phosphorylation | 3 | 2015 | 480 | 0.590 |
Why?
|
Myocardial Infarction | 8 | 2023 | 11708 | 0.590 |
Why?
|
Hypertension | 12 | 2023 | 8480 | 0.570 |
Why?
|
Propranolol | 1 | 2018 | 502 | 0.570 |
Why?
|
Cerebral Ventricles | 2 | 2019 | 542 | 0.560 |
Why?
|
Blood Circulation | 1 | 2017 | 251 | 0.550 |
Why?
|
Cytokines | 6 | 2019 | 7324 | 0.550 |
Why?
|
Aneurysm, Ruptured | 1 | 2021 | 452 | 0.540 |
Why?
|
Autophagy | 2 | 2015 | 1296 | 0.540 |
Why?
|
Neurology | 2 | 2024 | 764 | 0.540 |
Why?
|
Tissue Donors | 5 | 2013 | 2241 | 0.540 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2016 | 113 | 0.530 |
Why?
|
Fibrinolytic Agents | 2 | 2023 | 2159 | 0.530 |
Why?
|
Liver Neoplasms | 9 | 2014 | 4251 | 0.530 |
Why?
|
Hepatitis E virus | 1 | 2016 | 71 | 0.520 |
Why?
|
Urinary Tract Infections | 3 | 2018 | 788 | 0.520 |
Why?
|
Hepatitis E | 1 | 2016 | 76 | 0.510 |
Why?
|
Proto-Oncogene Proteins | 3 | 2015 | 4552 | 0.510 |
Why?
|
Hepatectomy | 3 | 2011 | 550 | 0.510 |
Why?
|
Spectrum Analysis | 1 | 2017 | 454 | 0.510 |
Why?
|
Hematoma, Subdural, Intracranial | 1 | 2015 | 33 | 0.510 |
Why?
|
Apolipoprotein E2 | 5 | 2018 | 127 | 0.490 |
Why?
|
Male | 116 | 2023 | 349776 | 0.480 |
Why?
|
End Stage Liver Disease | 3 | 2014 | 314 | 0.470 |
Why?
|
Spectrometry, Fluorescence | 3 | 2004 | 688 | 0.470 |
Why?
|
Middle Aged | 89 | 2023 | 213241 | 0.470 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2013 | 95 | 0.460 |
Why?
|
Photoelectron Spectroscopy | 1 | 2013 | 12 | 0.460 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2021 | 1018 | 0.460 |
Why?
|
Tissue Survival | 1 | 2013 | 118 | 0.440 |
Why?
|
Female | 112 | 2023 | 380020 | 0.440 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1240 | 0.430 |
Why?
|
Aged | 80 | 2022 | 163178 | 0.430 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 2200 | 0.430 |
Why?
|
Triglycerides | 5 | 2022 | 2453 | 0.420 |
Why?
|
Pre-Eclampsia | 2 | 2019 | 1200 | 0.420 |
Why?
|
Aged, 80 and over | 48 | 2021 | 57744 | 0.420 |
Why?
|
Hemostasis, Surgical | 2 | 2010 | 128 | 0.410 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 1197 | 0.410 |
Why?
|
Ruthenium Red | 3 | 2007 | 19 | 0.410 |
Why?
|
Erythema | 1 | 2013 | 257 | 0.400 |
Why?
|
Living Donors | 3 | 2014 | 621 | 0.400 |
Why?
|
Temperature | 1 | 2018 | 2202 | 0.400 |
Why?
|
Rats, Zucker | 5 | 2015 | 128 | 0.390 |
Why?
|
Metabolic Diseases | 1 | 2018 | 658 | 0.390 |
Why?
|
Cholesterol | 2 | 2020 | 2922 | 0.380 |
Why?
|
Immunocompromised Host | 1 | 2016 | 847 | 0.380 |
Why?
|
Genes, Mitochondrial | 1 | 2010 | 61 | 0.370 |
Why?
|
Ischemia | 5 | 2019 | 1907 | 0.370 |
Why?
|
Calcium | 6 | 2019 | 5755 | 0.370 |
Why?
|
Genetic Association Studies | 7 | 2018 | 2703 | 0.370 |
Why?
|
Intracranial Embolism | 2 | 2018 | 202 | 0.370 |
Why?
|
Apolipoproteins E | 6 | 2019 | 1436 | 0.360 |
Why?
|
Anticoagulants | 8 | 2023 | 4599 | 0.360 |
Why?
|
Critical Care | 2 | 2020 | 2647 | 0.350 |
Why?
|
Graft Survival | 9 | 2014 | 3734 | 0.350 |
Why?
|
Thrombin | 2 | 2010 | 598 | 0.350 |
Why?
|
Models, Animal | 4 | 2019 | 2172 | 0.350 |
Why?
|
Pneumonia | 3 | 2018 | 2133 | 0.350 |
Why?
|
Apoptosis | 4 | 2013 | 9718 | 0.330 |
Why?
|
Methanol | 2 | 2008 | 85 | 0.330 |
Why?
|
Biliary Tract Diseases | 1 | 2009 | 161 | 0.330 |
Why?
|
Cell Death | 2 | 2004 | 1705 | 0.330 |
Why?
|
Genes | 1 | 2013 | 1893 | 0.330 |
Why?
|
Dioxolanes | 1 | 2008 | 25 | 0.320 |
Why?
|
Cholestasis | 1 | 2011 | 378 | 0.320 |
Why?
|
Genomics | 3 | 2023 | 5714 | 0.320 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2021 | 585 | 0.320 |
Why?
|
Cholangiocarcinoma | 2 | 2004 | 516 | 0.320 |
Why?
|
Neurologic Examination | 1 | 2011 | 929 | 0.320 |
Why?
|
RNA, Viral | 2 | 2016 | 2901 | 0.320 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2010 | 535 | 0.320 |
Why?
|
Glutamic Acid | 1 | 2013 | 1168 | 0.310 |
Why?
|
Liver Failure | 3 | 2013 | 241 | 0.310 |
Why?
|
Eczema | 2 | 2023 | 231 | 0.310 |
Why?
|
Epilepsy | 1 | 2023 | 3284 | 0.300 |
Why?
|
Membrane Proteins | 2 | 2015 | 7880 | 0.300 |
Why?
|
Cerebral Angiography | 4 | 2018 | 1285 | 0.300 |
Why?
|
Naphthalenes | 1 | 2008 | 194 | 0.300 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2007 | 71 | 0.300 |
Why?
|
Leukoaraiosis | 2 | 2020 | 118 | 0.290 |
Why?
|
Genotype | 16 | 2019 | 12944 | 0.290 |
Why?
|
Sepsis | 2 | 2018 | 2593 | 0.290 |
Why?
|
Tissue Preservation | 1 | 2007 | 180 | 0.290 |
Why?
|
Magnesium | 2 | 2021 | 813 | 0.290 |
Why?
|
Kidney Diseases | 1 | 2018 | 2146 | 0.280 |
Why?
|
Sex Characteristics | 1 | 2017 | 2583 | 0.280 |
Why?
|
Hepatitis C | 3 | 2011 | 1591 | 0.280 |
Why?
|
Warfarin | 4 | 2017 | 1497 | 0.280 |
Why?
|
Decompression, Surgical | 1 | 2011 | 594 | 0.280 |
Why?
|
Case-Control Studies | 20 | 2023 | 21733 | 0.280 |
Why?
|
Liver Diseases | 2 | 2012 | 1253 | 0.280 |
Why?
|
Kidney | 2 | 2020 | 7185 | 0.280 |
Why?
|
Cohort Studies | 25 | 2022 | 40545 | 0.270 |
Why?
|
Catheterization | 1 | 2011 | 1469 | 0.270 |
Why?
|
Tissue Plasminogen Activator | 2 | 2020 | 1263 | 0.270 |
Why?
|
Drainage | 1 | 2011 | 1142 | 0.270 |
Why?
|
Aspartate Aminotransferase, Mitochondrial | 1 | 2005 | 2 | 0.270 |
Why?
|
Cyclic N-Oxides | 1 | 2005 | 78 | 0.270 |
Why?
|
Collagen Type IV | 2 | 2017 | 140 | 0.270 |
Why?
|
Immunity | 1 | 2011 | 1013 | 0.260 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2014 | 2217 | 0.260 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.260 |
Why?
|
Genetic Loci | 6 | 2021 | 2575 | 0.260 |
Why?
|
Prefrontal Cortex | 3 | 2021 | 2147 | 0.260 |
Why?
|
Hepacivirus | 2 | 2011 | 1378 | 0.250 |
Why?
|
Blood Pressure | 9 | 2022 | 8551 | 0.250 |
Why?
|
Ticlopidine | 1 | 2010 | 899 | 0.250 |
Why?
|
Swine | 3 | 2020 | 5909 | 0.250 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1146 | 0.250 |
Why?
|
Risk Assessment | 15 | 2023 | 23327 | 0.250 |
Why?
|
Cholesterol, LDL | 4 | 2022 | 2354 | 0.240 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2739 | 0.230 |
Why?
|
Psoriasis | 1 | 2012 | 901 | 0.230 |
Why?
|
Cholesterol, HDL | 3 | 2020 | 1813 | 0.230 |
Why?
|
Linkage Disequilibrium | 3 | 2020 | 1996 | 0.230 |
Why?
|
Stress, Physiological | 1 | 2011 | 1403 | 0.220 |
Why?
|
Administration, Cutaneous | 2 | 2018 | 710 | 0.220 |
Why?
|
Postoperative Complications | 4 | 2016 | 15281 | 0.220 |
Why?
|
Rats | 11 | 2019 | 24250 | 0.220 |
Why?
|
Incidence | 11 | 2022 | 20948 | 0.220 |
Why?
|
Dioxanes | 1 | 2002 | 37 | 0.220 |
Why?
|
Lung Transplantation | 1 | 2011 | 1155 | 0.220 |
Why?
|
Statistics as Topic | 2 | 2019 | 2369 | 0.220 |
Why?
|
Chemokine CXCL10 | 1 | 2023 | 305 | 0.220 |
Why?
|
Catheter Ablation | 3 | 2004 | 2758 | 0.220 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1885 | 0.210 |
Why?
|
C-Reactive Protein | 3 | 2023 | 3778 | 0.210 |
Why?
|
Hernia, Hiatal | 1 | 2003 | 79 | 0.210 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2004 | 295 | 0.210 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2003 | 95 | 0.210 |
Why?
|
Stereoisomerism | 7 | 2009 | 624 | 0.210 |
Why?
|
Gallbladder Neoplasms | 1 | 2004 | 182 | 0.210 |
Why?
|
Longitudinal Studies | 12 | 2022 | 13980 | 0.210 |
Why?
|
Taurochenodeoxycholic Acid | 2 | 2013 | 34 | 0.210 |
Why?
|
Biliary Tract Neoplasms | 1 | 2004 | 178 | 0.200 |
Why?
|
Recurrence | 8 | 2021 | 8337 | 0.200 |
Why?
|
Portal Vein | 1 | 2004 | 437 | 0.200 |
Why?
|
Adenosine Triphosphate | 2 | 2007 | 2029 | 0.200 |
Why?
|
Diaphragm | 1 | 2003 | 349 | 0.200 |
Why?
|
Research | 2 | 2022 | 1999 | 0.200 |
Why?
|
Survivors | 3 | 2023 | 2291 | 0.200 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18027 | 0.200 |
Why?
|
Severity of Illness Index | 9 | 2023 | 15526 | 0.190 |
Why?
|
Seizures | 3 | 2023 | 2850 | 0.190 |
Why?
|
Neural Pathways | 3 | 2021 | 2971 | 0.190 |
Why?
|
Nervous System Diseases | 1 | 2011 | 1619 | 0.190 |
Why?
|
Mannose-Binding Lectin | 1 | 2022 | 150 | 0.190 |
Why?
|
Interleukin-6 | 3 | 2023 | 3208 | 0.190 |
Why?
|
Dielectric Spectroscopy | 1 | 2020 | 32 | 0.190 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 1143 | 0.190 |
Why?
|
Valproic Acid | 1 | 2023 | 445 | 0.190 |
Why?
|
Intracranial Hemorrhages | 2 | 2016 | 855 | 0.180 |
Why?
|
Models, Molecular | 3 | 2009 | 5445 | 0.180 |
Why?
|
Adult | 33 | 2021 | 213889 | 0.180 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 20 | 0.180 |
Why?
|
Animals | 24 | 2020 | 168660 | 0.180 |
Why?
|
Kidney Function Tests | 2 | 2020 | 684 | 0.180 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6620 | 0.180 |
Why?
|
Electrocardiography | 3 | 2023 | 6441 | 0.180 |
Why?
|
Skin Physiological Phenomena | 1 | 2020 | 180 | 0.180 |
Why?
|
Arteriolosclerosis | 1 | 2019 | 21 | 0.180 |
Why?
|
Infusions, Intravenous | 1 | 2005 | 2274 | 0.180 |
Why?
|
Alleles | 3 | 2018 | 6934 | 0.180 |
Why?
|
Keratosis, Actinic | 1 | 2020 | 74 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2022 | 3255 | 0.170 |
Why?
|
Prospective Studies | 18 | 2023 | 53250 | 0.170 |
Why?
|
Hyperlipidemias | 3 | 2019 | 789 | 0.170 |
Why?
|
Cryopreservation | 1 | 2004 | 671 | 0.170 |
Why?
|
Retrospective Studies | 23 | 2021 | 77410 | 0.170 |
Why?
|
Length of Stay | 2 | 2011 | 6311 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 18 | 2023 | 35409 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 14 | 2022 | 20121 | 0.160 |
Why?
|
Transplantation, Homologous | 3 | 2011 | 4777 | 0.160 |
Why?
|
Brain | 7 | 2024 | 26345 | 0.160 |
Why?
|
Proteins | 1 | 2013 | 6098 | 0.160 |
Why?
|
Bile Duct Neoplasms | 1 | 2004 | 567 | 0.160 |
Why?
|
Time Factors | 13 | 2021 | 40038 | 0.160 |
Why?
|
Atrophy | 2 | 2020 | 1577 | 0.160 |
Why?
|
Polymers | 1 | 2005 | 1621 | 0.160 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2019 | 129 | 0.160 |
Why?
|
Intensive Care Units | 1 | 2011 | 3679 | 0.160 |
Why?
|
Obesity | 5 | 2023 | 12744 | 0.160 |
Why?
|
PPAR alpha | 1 | 2019 | 198 | 0.160 |
Why?
|
Placental Insufficiency | 1 | 2018 | 51 | 0.150 |
Why?
|
Forehead | 1 | 2018 | 69 | 0.150 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2010 | 3070 | 0.150 |
Why?
|
Excipients | 1 | 2017 | 96 | 0.150 |
Why?
|
Mitochondria | 3 | 2007 | 3513 | 0.150 |
Why?
|
Remote Consultation | 1 | 2020 | 239 | 0.150 |
Why?
|
Chaplaincy Service, Hospital | 1 | 2017 | 22 | 0.150 |
Why?
|
Pharmacogenetics | 1 | 2021 | 674 | 0.150 |
Why?
|
Gene Frequency | 4 | 2014 | 3585 | 0.150 |
Why?
|
Silicon | 1 | 2017 | 145 | 0.150 |
Why?
|
Sternum | 1 | 2018 | 177 | 0.150 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1731 | 0.150 |
Why?
|
Catalysis | 3 | 2008 | 762 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1434 | 0.140 |
Why?
|
Hand Dermatoses | 1 | 2017 | 61 | 0.140 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2217 | 0.140 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2018 | 437 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2013 | 8939 | 0.140 |
Why?
|
Biliary Atresia | 2 | 2014 | 73 | 0.140 |
Why?
|
Multifactorial Inheritance | 2 | 2022 | 1195 | 0.140 |
Why?
|
Placenta Diseases | 1 | 2019 | 199 | 0.140 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15142 | 0.140 |
Why?
|
Caspase 3 | 2 | 2012 | 758 | 0.140 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2016 | 47 | 0.140 |
Why?
|
Alcohols | 2 | 2007 | 92 | 0.140 |
Why?
|
Stomach Diseases | 1 | 2017 | 134 | 0.140 |
Why?
|
Hypoalbuminemia | 1 | 2017 | 86 | 0.140 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 620 | 0.140 |
Why?
|
Dermatitis, Atopic | 1 | 2023 | 654 | 0.140 |
Why?
|
Treatment Outcome | 18 | 2021 | 63042 | 0.140 |
Why?
|
Models, Cardiovascular | 1 | 2021 | 996 | 0.140 |
Why?
|
Pastoral Care | 1 | 2017 | 73 | 0.140 |
Why?
|
Observer Variation | 2 | 2019 | 2592 | 0.130 |
Why?
|
Tissue and Organ Procurement | 2 | 2014 | 896 | 0.130 |
Why?
|
Choristoma | 1 | 2017 | 213 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 858 | 0.130 |
Why?
|
Vasodilation | 1 | 2019 | 944 | 0.130 |
Why?
|
Spectrum Analysis, Raman | 1 | 2017 | 247 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2017 | 367 | 0.130 |
Why?
|
Carotid Artery Diseases | 1 | 2022 | 875 | 0.130 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2017 | 352 | 0.130 |
Why?
|
Hypocalcemia | 1 | 2016 | 191 | 0.130 |
Why?
|
Pons | 1 | 2016 | 244 | 0.130 |
Why?
|
Europe | 5 | 2022 | 3336 | 0.130 |
Why?
|
Cytochromes c | 2 | 2007 | 180 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2004 | 2016 | 0.130 |
Why?
|
Missouri | 2 | 2011 | 117 | 0.130 |
Why?
|
Models, Genetic | 3 | 2021 | 3492 | 0.130 |
Why?
|
Brain Stem Hemorrhage, Traumatic | 1 | 2014 | 13 | 0.130 |
Why?
|
Fingers | 1 | 2018 | 513 | 0.120 |
Why?
|
Zinc Fingers | 1 | 2017 | 583 | 0.120 |
Why?
|
Lymphopenia | 1 | 2017 | 285 | 0.120 |
Why?
|
Cadaver | 2 | 2019 | 1335 | 0.120 |
Why?
|
Rats, Wistar | 1 | 2018 | 1892 | 0.120 |
Why?
|
Caspases | 2 | 2011 | 928 | 0.120 |
Why?
|
Carcinoma, Basal Cell | 1 | 2020 | 545 | 0.120 |
Why?
|
bcl-2-Associated X Protein | 2 | 2007 | 295 | 0.120 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2167 | 0.120 |
Why?
|
Type C Phospholipases | 2 | 2006 | 292 | 0.120 |
Why?
|
Mitochondria, Liver | 2 | 2006 | 187 | 0.120 |
Why?
|
Embolization, Therapeutic | 1 | 2004 | 1392 | 0.120 |
Why?
|
Drug Discovery | 1 | 2022 | 1058 | 0.120 |
Why?
|
Peroxidase | 1 | 2017 | 611 | 0.120 |
Why?
|
Age Factors | 8 | 2021 | 18355 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2022 | 1041 | 0.120 |
Why?
|
Head | 1 | 2019 | 878 | 0.120 |
Why?
|
Depression | 3 | 2022 | 7760 | 0.120 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1525 | 0.120 |
Why?
|
Plasma | 1 | 2017 | 575 | 0.120 |
Why?
|
Serum Albumin | 1 | 2017 | 675 | 0.120 |
Why?
|
Hepatorenal Syndrome | 1 | 2014 | 61 | 0.120 |
Why?
|
Embolism | 1 | 2017 | 407 | 0.120 |
Why?
|
Sweden | 3 | 2023 | 1341 | 0.120 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 2647 | 0.120 |
Why?
|
Follow-Up Studies | 13 | 2021 | 39001 | 0.120 |
Why?
|
Principal Component Analysis | 3 | 2014 | 935 | 0.120 |
Why?
|
Sex Factors | 5 | 2020 | 10394 | 0.110 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2017 | 507 | 0.110 |
Why?
|
Tunicamycin | 1 | 2013 | 112 | 0.110 |
Why?
|
Antineoplastic Agents | 3 | 2013 | 13691 | 0.110 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2019 | 489 | 0.110 |
Why?
|
Electron Transport Complex I | 1 | 2014 | 140 | 0.110 |
Why?
|
Molecular Structure | 5 | 2008 | 1894 | 0.110 |
Why?
|
Cerebral Infarction | 2 | 2015 | 1011 | 0.110 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2013 | 60 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2020 | 2712 | 0.110 |
Why?
|
Lung | 1 | 2011 | 9858 | 0.110 |
Why?
|
Liver Failure, Acute | 1 | 2014 | 165 | 0.110 |
Why?
|
Survival Rate | 6 | 2021 | 12786 | 0.110 |
Why?
|
Cytosol | 2 | 2007 | 901 | 0.110 |
Why?
|
Placenta | 2 | 2019 | 1699 | 0.110 |
Why?
|
Nanostructures | 1 | 2017 | 552 | 0.110 |
Why?
|
Overweight | 1 | 2023 | 2371 | 0.110 |
Why?
|
Choledochal Cyst | 1 | 2012 | 25 | 0.110 |
Why?
|
Cerebellar Diseases | 1 | 2014 | 226 | 0.110 |
Why?
|
Risk | 4 | 2018 | 9677 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2016 | 1588 | 0.100 |
Why?
|
Odds Ratio | 5 | 2021 | 9848 | 0.100 |
Why?
|
Chromatin | 1 | 2023 | 2931 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 941 | 0.100 |
Why?
|
Alzheimer Disease | 5 | 2014 | 8035 | 0.100 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2014 | 657 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2210 | 0.100 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2013 | 471 | 0.100 |
Why?
|
Transaminases | 1 | 2012 | 200 | 0.100 |
Why?
|
Amyloid beta-Peptides | 2 | 2023 | 3587 | 0.100 |
Why?
|
Cholangiography | 1 | 2011 | 189 | 0.100 |
Why?
|
Androstadienes | 1 | 2013 | 345 | 0.100 |
Why?
|
Hepatitis B Antibodies | 1 | 2011 | 158 | 0.100 |
Why?
|
Child | 9 | 2023 | 77637 | 0.100 |
Why?
|
Tissue Culture Techniques | 1 | 2012 | 291 | 0.100 |
Why?
|
Acrolein | 2 | 2009 | 21 | 0.100 |
Why?
|
Liver Cirrhosis | 2 | 2011 | 1859 | 0.100 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2012 | 326 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1832 | 0.100 |
Why?
|
Registries | 4 | 2023 | 8090 | 0.100 |
Why?
|
Statistics, Nonparametric | 4 | 2017 | 2883 | 0.100 |
Why?
|
Hemodynamics | 2 | 2019 | 4197 | 0.100 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 12066 | 0.090 |
Why?
|
Activating Transcription Factor 4 | 1 | 2011 | 81 | 0.090 |
Why?
|
Jejunal Neoplasms | 1 | 2010 | 18 | 0.090 |
Why?
|
Forearm | 1 | 2013 | 409 | 0.090 |
Why?
|
Influenza Vaccines | 1 | 2018 | 738 | 0.090 |
Why?
|
Radiography | 4 | 2015 | 7010 | 0.090 |
Why?
|
Pancreas | 1 | 2017 | 1686 | 0.090 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2013 | 637 | 0.090 |
Why?
|
Medulla Oblongata | 1 | 2011 | 243 | 0.090 |
Why?
|
Lipoproteins | 1 | 2015 | 881 | 0.090 |
Why?
|
Health Care Rationing | 1 | 2013 | 437 | 0.090 |
Why?
|
Kinetics | 1 | 2018 | 6476 | 0.090 |
Why?
|
Colorectal Neoplasms | 1 | 2010 | 6773 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1670 | 0.090 |
Why?
|
Waiting Lists | 1 | 2014 | 692 | 0.090 |
Why?
|
Specimen Handling | 1 | 2014 | 694 | 0.090 |
Why?
|
Protein Transport | 2 | 2007 | 1988 | 0.090 |
Why?
|
Pregnancy | 4 | 2019 | 29140 | 0.090 |
Why?
|
Glasgow Coma Scale | 1 | 2011 | 570 | 0.090 |
Why?
|
Pyramidal Tracts | 1 | 2011 | 255 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 850 | 0.090 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 257 | 0.090 |
Why?
|
Boronic Acids | 1 | 2013 | 965 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2760 | 0.090 |
Why?
|
Survival Analysis | 5 | 2021 | 10251 | 0.080 |
Why?
|
Biopsy | 2 | 2011 | 6750 | 0.080 |
Why?
|
Hepatoblastoma | 2 | 2013 | 87 | 0.080 |
Why?
|
Reoperation | 4 | 2011 | 4200 | 0.080 |
Why?
|
Blood Specimen Collection | 1 | 2010 | 246 | 0.080 |
Why?
|
Prognosis | 7 | 2018 | 29052 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2021 | 3817 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12243 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2010 | 411 | 0.080 |
Why?
|
Lipids | 1 | 2020 | 3307 | 0.080 |
Why?
|
Alkenes | 1 | 2008 | 57 | 0.080 |
Why?
|
Hepatitis B virus | 1 | 2011 | 513 | 0.080 |
Why?
|
Cells, Cultured | 2 | 2015 | 19232 | 0.080 |
Why?
|
Tracheostomy | 1 | 2011 | 401 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2019 | 19894 | 0.080 |
Why?
|
Molecular Chaperones | 1 | 2012 | 742 | 0.080 |
Why?
|
Pyrazines | 1 | 2013 | 1230 | 0.080 |
Why?
|
Hemostatics | 1 | 2010 | 229 | 0.080 |
Why?
|
Young Adult | 9 | 2019 | 56392 | 0.080 |
Why?
|
Adenine | 1 | 2013 | 935 | 0.080 |
Why?
|
Boron Compounds | 1 | 2009 | 175 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2023 | 3445 | 0.080 |
Why?
|
Preoperative Care | 2 | 2008 | 2251 | 0.070 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2008 | 131 | 0.070 |
Why?
|
Chemokines | 1 | 2011 | 968 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2012 | 1396 | 0.070 |
Why?
|
Hydrocarbons, Acyclic | 1 | 2006 | 1 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2019 | 4459 | 0.070 |
Why?
|
Inflammation Mediators | 2 | 2019 | 1888 | 0.070 |
Why?
|
Hepatitis B, Chronic | 1 | 2011 | 392 | 0.070 |
Why?
|
Aldehydes | 1 | 2008 | 167 | 0.070 |
Why?
|
Benzaldehydes | 1 | 2007 | 58 | 0.070 |
Why?
|
Administration, Topical | 1 | 2009 | 689 | 0.070 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 424 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1480 | 0.070 |
Why?
|
Dermatology | 1 | 2017 | 872 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 820 | 0.070 |
Why?
|
Immunoassay | 1 | 2010 | 751 | 0.070 |
Why?
|
Neocortex | 1 | 2010 | 399 | 0.070 |
Why?
|
Models, Chemical | 2 | 2007 | 626 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3439 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1637 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7793 | 0.070 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 885 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2011 | 1200 | 0.070 |
Why?
|
Endosonography | 1 | 2010 | 610 | 0.070 |
Why?
|
Constriction, Pathologic | 1 | 2009 | 1108 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2014 | 1029 | 0.070 |
Why?
|
Arousal | 1 | 2011 | 1160 | 0.070 |
Why?
|
Lactones | 1 | 2008 | 329 | 0.070 |
Why?
|
Treatment Failure | 1 | 2011 | 2617 | 0.070 |
Why?
|
Glycoproteins | 1 | 2013 | 2266 | 0.070 |
Why?
|
Interleukin-17 | 1 | 2011 | 902 | 0.070 |
Why?
|
Body Mass Index | 5 | 2023 | 12718 | 0.070 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15067 | 0.070 |
Why?
|
Proteomics | 2 | 2023 | 3639 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3504 | 0.070 |
Why?
|
Triazines | 1 | 2007 | 315 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2011 | 11036 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2011 | 973 | 0.060 |
Why?
|
Liver Circulation | 1 | 2005 | 164 | 0.060 |
Why?
|
Genetics, Population | 1 | 2010 | 933 | 0.060 |
Why?
|
DNA, Mitochondrial | 1 | 2010 | 815 | 0.060 |
Why?
|
Blood Coagulation | 1 | 2010 | 1127 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2012 | 1416 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 623 | 0.060 |
Why?
|
Adenine Nucleotides | 1 | 2004 | 121 | 0.060 |
Why?
|
Quantitative Trait Loci | 3 | 2018 | 2018 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4033 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2670 | 0.060 |
Why?
|
Disease Progression | 5 | 2020 | 13273 | 0.060 |
Why?
|
Child, Preschool | 6 | 2013 | 40964 | 0.060 |
Why?
|
Biosensing Techniques | 1 | 2010 | 667 | 0.060 |
Why?
|
Reperfusion | 1 | 2005 | 283 | 0.060 |
Why?
|
Optical Fibers | 1 | 2004 | 138 | 0.060 |
Why?
|
Acetates | 1 | 2005 | 310 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2012 | 5078 | 0.060 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2010 | 646 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2019 | 14563 | 0.060 |
Why?
|
Cold Temperature | 1 | 2007 | 771 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1213 | 0.060 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2010 | 828 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2011 | 1743 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10629 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 2 | 2013 | 1444 | 0.060 |
Why?
|
Receptors, Purinergic P2 | 1 | 2004 | 153 | 0.060 |
Why?
|
Indicators and Reagents | 1 | 2004 | 462 | 0.060 |
Why?
|
Optical Rotation | 1 | 2002 | 12 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2011 | 3205 | 0.060 |
Why?
|
Single-Blind Method | 2 | 2018 | 1586 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2010 | 1256 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14714 | 0.050 |
Why?
|
Cell Survival | 1 | 2013 | 5881 | 0.050 |
Why?
|
Fiber Optic Technology | 1 | 2004 | 290 | 0.050 |
Why?
|
Collagen | 1 | 2011 | 2681 | 0.050 |
Why?
|
Dogs | 2 | 2004 | 3911 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2005 | 593 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2016 | 5316 | 0.050 |
Why?
|
United States | 7 | 2021 | 69859 | 0.050 |
Why?
|
Polytetrafluoroethylene | 1 | 2003 | 233 | 0.050 |
Why?
|
Dementia | 1 | 2016 | 2518 | 0.050 |
Why?
|
Methods | 1 | 2002 | 1128 | 0.050 |
Why?
|
Carcinoid Tumor | 1 | 2003 | 235 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3463 | 0.050 |
Why?
|
NF-kappa B | 1 | 2011 | 2500 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2006 | 8300 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2010 | 2727 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2005 | 730 | 0.050 |
Why?
|
Drug Repositioning | 1 | 2024 | 230 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5508 | 0.050 |
Why?
|
Biological Factors | 1 | 2002 | 164 | 0.050 |
Why?
|
Hong Kong | 1 | 2021 | 148 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2534 | 0.050 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1188 | 0.050 |
Why?
|
Necrosis | 1 | 2005 | 1642 | 0.050 |
Why?
|
Lipogenesis | 1 | 2022 | 212 | 0.050 |
Why?
|
Surgical Mesh | 1 | 2003 | 276 | 0.050 |
Why?
|
Logistic Models | 4 | 2018 | 13404 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5691 | 0.050 |
Why?
|
Diphosphonates | 1 | 2005 | 622 | 0.050 |
Why?
|
Africa | 1 | 2022 | 672 | 0.050 |
Why?
|
Adolescent | 9 | 2019 | 85729 | 0.050 |
Why?
|
Cognition Disorders | 2 | 2011 | 4041 | 0.040 |
Why?
|
Antidepressive Agents | 2 | 2022 | 2837 | 0.040 |
Why?
|
Electronic Health Records | 3 | 2022 | 4467 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 2961 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2850 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12354 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2017 | 5264 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 7908 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2505 | 0.040 |
Why?
|
Stents | 1 | 2011 | 3280 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2916 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.040 |
Why?
|
Isoenzymes | 1 | 2004 | 1728 | 0.040 |
Why?
|
Signal Transduction | 2 | 2014 | 23398 | 0.040 |
Why?
|
Biological Products | 1 | 2008 | 859 | 0.040 |
Why?
|
Adenosine | 1 | 2004 | 825 | 0.040 |
Why?
|
Apolipoprotein B-100 | 1 | 2019 | 148 | 0.040 |
Why?
|
Mutation | 2 | 2023 | 29777 | 0.040 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 2018 | 77 | 0.040 |
Why?
|
Recovery of Function | 2 | 2019 | 2922 | 0.040 |
Why?
|
Cerebral Cortex | 2 | 2013 | 5692 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2020 | 516 | 0.040 |
Why?
|
Hot Temperature | 1 | 2004 | 1351 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4251 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1770 | 0.040 |
Why?
|
Automation | 1 | 2020 | 584 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4033 | 0.040 |
Why?
|
Australia | 1 | 2021 | 1167 | 0.040 |
Why?
|
Vaccines, Inactivated | 1 | 2018 | 184 | 0.040 |
Why?
|
Education | 1 | 2021 | 543 | 0.040 |
Why?
|
Antioxidants | 1 | 2005 | 1658 | 0.040 |
Why?
|
Algorithms | 2 | 2020 | 13869 | 0.040 |
Why?
|
Organ Size | 2 | 2014 | 2241 | 0.040 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 271 | 0.040 |
Why?
|
Coronary Artery Disease | 2 | 2023 | 6485 | 0.040 |
Why?
|
Cyclization | 2 | 2008 | 65 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 21824 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7270 | 0.040 |
Why?
|
New England | 1 | 2020 | 1022 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2004 | 1524 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2018 | 553 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11360 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 279 | 0.040 |
Why?
|
Nonlinear Dynamics | 1 | 2019 | 501 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2002 | 3128 | 0.040 |
Why?
|
Molecular Conformation | 2 | 2009 | 561 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2019 | 6356 | 0.040 |
Why?
|
Blood Component Transfusion | 1 | 2017 | 143 | 0.040 |
Why?
|
Hydrogen Bonding | 2 | 2007 | 291 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9582 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 2 | 2010 | 524 | 0.030 |
Why?
|
Surgery, Computer-Assisted | 1 | 2004 | 1017 | 0.030 |
Why?
|
Needles | 1 | 2019 | 449 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16361 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25032 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2004 | 6311 | 0.030 |
Why?
|
Massachusetts | 2 | 2020 | 8660 | 0.030 |
Why?
|
Research Subjects | 1 | 2017 | 239 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10380 | 0.030 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2019 | 500 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2004 | 3480 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5854 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 847 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2017 | 230 | 0.030 |
Why?
|
Infant | 3 | 2011 | 35122 | 0.030 |
Why?
|
Vitamin K | 1 | 2017 | 295 | 0.030 |
Why?
|
Leukocytosis | 1 | 2016 | 247 | 0.030 |
Why?
|
Antifibrinolytic Agents | 1 | 2017 | 254 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15211 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1809 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 659 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 851 | 0.030 |
Why?
|
Computational Biology | 2 | 2018 | 3515 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 7729 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 950 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1431 | 0.030 |
Why?
|
Smoking | 2 | 2021 | 8984 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1674 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2021 | 1656 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2023 | 2073 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1579 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3527 | 0.030 |
Why?
|
Warm Ischemia | 1 | 2012 | 53 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1503 | 0.030 |
Why?
|
Aging | 1 | 2011 | 8655 | 0.030 |
Why?
|
Hospitals, University | 1 | 2014 | 570 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 278 | 0.030 |
Why?
|
Entorhinal Cortex | 1 | 2014 | 271 | 0.030 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 6 | 0.030 |
Why?
|
Quality of Life | 2 | 2023 | 12788 | 0.030 |
Why?
|
Biomedical Research | 2 | 2021 | 3308 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2015 | 633 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1073 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1877 | 0.020 |
Why?
|
Program Evaluation | 1 | 2020 | 2483 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2307 | 0.020 |
Why?
|
Quality Control | 1 | 2014 | 841 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2022 | 2727 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1782 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3503 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16674 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2016 | 6976 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2021 | 2305 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2162 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2013 | 546 | 0.020 |
Why?
|
Databases, Protein | 1 | 2012 | 383 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 3912 | 0.020 |
Why?
|
Hippocampus | 2 | 2014 | 3672 | 0.020 |
Why?
|
Hernia, Diaphragmatic | 1 | 2010 | 250 | 0.020 |
Why?
|
Adiposity | 1 | 2019 | 1806 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6895 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2004 | 3503 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1707 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9139 | 0.020 |
Why?
|
Population Groups | 1 | 2010 | 209 | 0.020 |
Why?
|
Nerve Net | 1 | 2021 | 2173 | 0.020 |
Why?
|
Butadienes | 1 | 2009 | 110 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
Acrylates | 1 | 2009 | 89 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2017 | 4737 | 0.020 |
Why?
|
Micromonospora | 1 | 2008 | 5 | 0.020 |
Why?
|
Graft Rejection | 2 | 2014 | 4398 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2015 | 1529 | 0.020 |
Why?
|
Vaccines | 1 | 2017 | 823 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2008 | 193 | 0.020 |
Why?
|
Palliative Care | 1 | 2004 | 3490 | 0.020 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2010 | 266 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1574 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4670 | 0.020 |
Why?
|
Pain Measurement | 1 | 2018 | 3420 | 0.020 |
Why?
|
Benzoquinones | 1 | 2009 | 201 | 0.020 |
Why?
|
Fumarates | 1 | 2009 | 132 | 0.020 |
Why?
|
Mice | 2 | 2012 | 81154 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 864 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3701 | 0.020 |
Why?
|
Thalamus | 1 | 2013 | 1023 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 651 | 0.020 |
Why?
|
Perioperative Care | 1 | 2014 | 1002 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2018 | 3175 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4031 | 0.020 |
Why?
|
Monocytes | 1 | 2016 | 2593 | 0.020 |
Why?
|
Blotting, Western | 2 | 2004 | 5179 | 0.020 |
Why?
|
Information Dissemination | 1 | 2014 | 1099 | 0.020 |
Why?
|
Transplants | 1 | 2008 | 209 | 0.020 |
Why?
|
Bromides | 1 | 2005 | 20 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2047 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2010 | 1340 | 0.020 |
Why?
|
Syndrome | 1 | 2012 | 3249 | 0.020 |
Why?
|
Immune System | 1 | 2011 | 807 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6259 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2011 | 993 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2012 | 2203 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5251 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2010 | 1094 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 3000 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9944 | 0.020 |
Why?
|
Receptors, Purinergic P2Y2 | 1 | 2004 | 18 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2010 | 934 | 0.020 |
Why?
|
Phospholipase C delta | 1 | 2004 | 7 | 0.020 |
Why?
|
Canada | 1 | 2010 | 2064 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3645 | 0.020 |
Why?
|
Estrenes | 1 | 2004 | 23 | 0.020 |
Why?
|
Calcium Channel Agonists | 1 | 2004 | 29 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2009 | 1802 | 0.020 |
Why?
|
Receptors, Purinergic P2Y1 | 1 | 2004 | 40 | 0.020 |
Why?
|
Coronary Disease | 1 | 2019 | 6078 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3020 | 0.020 |
Why?
|
Spermine | 1 | 2004 | 70 | 0.020 |
Why?
|
Stimulation, Chemical | 1 | 2004 | 326 | 0.020 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2004 | 114 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2013 | 2258 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3874 | 0.010 |
Why?
|
Steroids | 1 | 2009 | 930 | 0.010 |
Why?
|
Pyrrolidinones | 1 | 2004 | 117 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2010 | 1301 | 0.010 |
Why?
|
Clinical Competence | 1 | 2019 | 4687 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3718 | 0.010 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1452 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2004 | 211 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4221 | 0.010 |
Why?
|
Patient Compliance | 1 | 2013 | 2683 | 0.010 |
Why?
|
Proteome | 1 | 2012 | 1794 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3574 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2007 | 2011 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6170 | 0.010 |
Why?
|
Biological Transport | 1 | 2006 | 2119 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10259 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3740 | 0.010 |
Why?
|
Hyperthermia, Induced | 1 | 2004 | 404 | 0.010 |
Why?
|
tau Proteins | 1 | 2010 | 1869 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2004 | 2646 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4418 | 0.010 |
Why?
|
Calcium Channels | 1 | 2004 | 622 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6539 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 1081 | 0.010 |
Why?
|
Pediatrics | 1 | 2013 | 3474 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2010 | 3320 | 0.010 |
Why?
|
Software | 1 | 2011 | 4440 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2692 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2004 | 1903 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4152 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10940 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 2924 | 0.010 |
Why?
|
Heart Failure | 1 | 2019 | 10896 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 3758 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6188 | 0.010 |
Why?
|
Cell Membrane | 1 | 2004 | 3749 | 0.010 |
Why?
|
Burns | 1 | 2004 | 1815 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 9239 | 0.000 |
Why?
|